U.S. Communications Stock News

Inhibrx Biosciences (INBX) just gave investors a fresh look at its oncology pipeline, highlighting progress in INBRX-106 combo trials with Keytruda and ozekibart studies that could support meaningful FDA conversations in 2026. See our latest analysis for Inhibrx Biosciences. That steady clinical drumbeat has been mirrored in the market, with the share price at $83.09 after a 7.09 percent 1 month share price return and a powerful 444.85 percent year to date share price return, contributing to...

Lennar (LEN) has just wrapped up FY 2025 with fourth quarter revenue of about $9.4 billion and basic EPS of $1.94, setting the tone for a year in which trailing twelve month revenue came in at roughly $34.2 billion alongside EPS of $8.06. The company has seen quarterly revenue move from around $9.9 billion in Q4 2024 to $9.4 billion in Q4 2025, while basic EPS shifted from $4.06 to $1.94 over the same stretch, leaving investors focused on how much of that topline scale is now flowing through...

Paramount Group (PGRE) has quietly delivered a strong run for investors over the past year, even as office real estate remains out of favor. With shares up about 41% year over year, it is worth a closer look. See our latest analysis for Paramount Group. The stock’s 1 year total shareholder return of 41.42% alongside a 32.86% year to date share price return suggests sentiment has meaningfully improved, even if recent weekly moves have cooled. This signals momentum that is moderating rather...

Harmonic announced that Czech Television, the Czech Republic’s public broadcaster, has adopted Harmonic’s software-based XOS Advanced Media Processor to bring transcoding in-house and upgrade its streaming workflow with AI-powered encoding, multi-profile outputs, and inclusive audio features. This collaboration highlights growing adoption of Harmonic’s cloud-native XOS platform in Europe, reinforcing the company’s positioning in premium, broadcast-grade streaming solutions. We’ll now explore...

Children's Place (PLCE) just turned in a mixed Q3 2026 update, with revenue of about $339 million and a basic EPS loss of roughly $0.19 as the retailer continues to work through a difficult turnaround. The company has seen quarterly revenue move from around $320 million in Q2 2025 to $390 million in Q3 2025 and then to $339 million this quarter, while EPS has swung from a $2.51 loss in Q2 2025 to a $1.57 profit in Q3 2025 and back to losses of $0.24 in Q2 2026 and $0.19 in Q3 2026. This...

Hillenbrand (HI) has quietly ground higher this past quarter, leaving some investors wondering what is driving the move and whether the current price still reflects a reasonable entry point. See our latest analysis for Hillenbrand. At around $31.70, the recent 90 day share price return of roughly 25 percent suggests sentiment has turned more constructive, even though the longer term total shareholder returns have been negative. If Hillenbrand has you rethinking where the next leg of...

NASB Financial’s latest FY 2025 fourth quarter update put fresh numbers on the table, with revenue at about $23.2 million and EPS of $1.12, setting the tone for how investors will read the year in review. The company has seen quarterly revenue move from $20.8 million and EPS of $0.84 in Q4 2024 to $23.2 million and $1.12 in Q4 2025, while trailing twelve month revenue has hovered in the mid to high $80 million range and EPS around the mid to high $3.00s. This leaves investors to focus on how...

ABM Industries (ABM) has just posted its FY 2025 third quarter results with revenue of about $2.2 billion and EPS of $0.67, setting the tone for a year where margins and one off items are firmly in focus for investors. Over the past few quarters, the company has seen revenue move from $2.02 billion in Q2 FY 2024 to $2.11 billion in Q2 FY 2025 and then to $2.22 billion in Q3 FY 2025, while quarterly EPS has tracked in a tight band between roughly $0.67 and $0.70, pointing to stable...

Wondering if CBIZ is quietly setting up as a value play while the market is distracted elsewhere? Let us unpack what the current price is really implying about its future. CBIZ just closed at $53.49, and while it is up 5.6% over the past week and 4.6% over the last month, the stock is still down about 34.1% year to date and 34.5% over the past year, giving it a mixed performance profile that value focused investors tend to notice. Behind those swings, investors have been reacting to a steady...

If you have been wondering whether Flowers Foods is starting to look like a bargain or a value trap, you are not alone. This breakdown will give you the context you need before making a move. Despite a rough longer term stretch, with the stock down 43.6% over the last year and 46.4% year to date, the recent 4.1% gain over the past week after a 3.2% dip in the last month hints that sentiment may be trying to find a floor. Recent coverage has focused on Flowers Foods as a defensive consumer...

Wondering if Cooper Companies is quietly turning into a value opportunity after a rough patch? This article will walk you through what the numbers are really saying about the stock. After sliding earlier this year, the share price has bounced about 3.2% in the last week and 12.4% over the last month, even though it is still down 10.6% year to date and 14.2% over the past year. That rebound has come as investors refocus on Cooper's positioning in specialty contact lenses and women's health,...

Wondering if JBS at around $14.34 is quietly trading below what it is really worth? You are not alone, and this breakdown is designed to help you decide if the stock deserves a spot on your watchlist. Over the last week JBS is up 3.5%, building on an 8.1% gain over the past month and a 3.4% rise year to date. These moves hint that investors are starting to reassess the company’s risk and growth profile. Recent headlines have focused on JBS’s ongoing push to streamline operations and invest...

Wondering if Insight Enterprises is a beaten down opportunity or a value trap at today’s price? You are not the only one asking whether the current share price really reflects its underlying business. The stock has slid to around $79.62, with returns of about -6.3% over the last week, -11.6% over the last month, and a much steeper -46.7% year to date and -48.9% over the past year. This has reshaped how the market is pricing its future. Much of this shift has come as investors reassess IT...

Wondering if Crown Holdings at around $101.53 is still a smart buy or if most of the upside has already been priced in? Here is a closer look at what the current share price really implies about its value. The stock has climbed 7.8% over the last week, 4.5% over the past month, and is up 25.0% year to date, adding to a 20.2% gain over the last year that has many investors taking a fresh look. Some of this momentum reflects renewed interest in packaging names as investors rotate toward...

The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...

The board of The Toro Company ( NYSE:TTC ) has announced that it will be paying its dividend of $0.39 on the 12th of...

Some CME Group Inc. ( NASDAQ:CME ) shareholders may be a little concerned to see that the Chairman & CEO, Terrence...

Some The Carlyle Group Inc. ( NASDAQ:CG ) shareholders may be a little concerned to see that the Co-Founder...

Anyone interested in Cogent Communications Holdings, Inc. ( NASDAQ:CCOI ) should probably be aware that the VP, CFO...

If you are building a properly diversified stock portfolio, the chances are some of your picks will perform badly. But...

Kestra Medical Technologies (KMTS) has been quietly grinding higher, with the stock up around 2% on the day, nearly 9% over the past week, and roughly 24% year to date. See our latest analysis for Kestra Medical Technologies. That kind of steady climb in the share price, capped by a 1 day share price return of just under 2 percent, suggests momentum is building as investors warm to Kestra Medical Technologies growth story and reassess its risk profile. If this move in Kestra Medical...

Amidst a backdrop of declining major stock indexes, with the S&P 500 and Dow Jones Industrial Average experiencing their fourth consecutive losses due to AI bubble concerns and tepid labor data, the tech-heavy Nasdaq has also seen a recent decline. In this environment, identifying high-growth tech stocks requires careful consideration of companies that demonstrate resilience and potential for innovation despite broader market challenges.

As December 2025 unfolds, the U.S. stock market faces a challenging period with major indices like the S&P 500 and Dow Jones Industrial Average experiencing consecutive declines amid AI bubble concerns and rising unemployment rates. In such an environment, identifying undervalued stocks becomes crucial for investors seeking opportunities that may offer potential value relative to their intrinsic worth.

As the U.S. stock market experiences a pullback with major indices like the S&P 500 and Dow Jones facing consecutive losses, investors are increasingly cautious amid concerns over an AI bubble and tepid labor data. In such uncertain times, growth companies with high insider ownership can offer a compelling option as they often align management's interests with those of shareholders, potentially leading to sustained revenue growth despite broader market challenges.